A full-thickness scleral graft for the surgical management of a late filtration bleb leak.

Ophthalmic Surg Lasers

Glaucoma Clinic, St Paul's Eye Unit, Royal Liverpool University Hospital, United Kingdom.

Published: June 1997

Background And Objectives: Late bleb leak may follow months to years after filtration surgery. This article describes the surgical repair of eight leaking blebs using a full-thickness scleral graft and analyzes the efficacy of the procedure and its effect on intraocular pressure (IOP) control.

Patients And Methods: The indications for surgical bleb revision were hypotony maculopathy (2 eyes), endophthalmitis (2 eyes), bleb infection (2 eyes), and chronic epiphora and blurring of vision (2 eyes). All eyes were treated surgically through bleb excision and repair of the scleral defect with a full-thickness scleral graft. Conjunctival closure was performed either by its advancement to the limbus or by free conjunctival autograft. Follow-up ranged from 4 months to 7 years.

Results: Surgery stopped the leak in all cases, and hypotony was relieved without loss of long-term IOP control. However, early postoperative IOP rises (> 30 mm Hg) occurred in 2 eyes and a pressure-lowering medication was necessary to achieve long-term IOP control (IOP < 22 mm Hg) in 3 eyes.

Conclusions: The technique described is an effective procedure for the treatment of late bleb leaks and is especially useful for the treatment of leaks found in association with full-thickness scleral defects. IOP spikes in the early postoperative period may occur, but long-term IOP control can be expected without the need for further filtration surgery.

Download full-text PDF

Source

Publication Analysis

Top Keywords

full-thickness scleral
16
scleral graft
12
long-term iop
12
iop control
12
bleb leak
8
late bleb
8
filtration surgery
8
early postoperative
8
iop
7
bleb
6

Similar Publications

Purpose: To present a modified evisceration technique with a full-thickness horizontal sclerotomy and assess post-operative motility and long-term outcomes.

Methods: This is a retrospective chart review of patients who underwent evisceration with a single surgeon (TJM). The standard initial steps of evisceration were performed.

View Article and Find Full Text PDF

Background: Involution or aging is the most common cause of lower eyelid entropion (in-turning of eyelid margin) in the elderly population. Various pathomechanisms have been postulated for its occurrence. Aging leads to laxity of tissues and loss of muscle tone.

View Article and Find Full Text PDF

Macular Buckling for Myopic Traction Maculopathy: A Comprehensive Systematic Review and Meta-Analysis.

Am J Ophthalmol

February 2025

BayCare Clinic Eye Specialists (A.G.E.), Aurora BayCare Medical Center, Green Bay, Wisconsin, USA; Department of Ophthalmology (A.G.E.), Faculty of Medicine, Cairo University, Cairo, Egypt.

Article Synopsis
  • Myopic traction maculopathy is a significant cause of vision issues, especially in Asian populations, prompting the need to explore effective treatments like macular buckling.
  • A systematic review analyzed 13 studies involving 482 eyes, evaluating the impact of macular buckling on visual acuity, axial length, and the rates of retinal reattachment and macular hole closure.
  • The results indicated notable improvements in best-corrected visual acuity, consistent reductions in axial length, and high rates of retinal reattachment (94%) and macular hole closure (72%), suggesting that macular buckling is a beneficial treatment option.
View Article and Find Full Text PDF

Purpose: To describe an alternate surgical technique for fluocinolone acetonide (Retisert) implantation in patients with extensive pars plana and pars plicata fibrosis secondary to chronic non-infectious uveitis.

Methods: This retrospective, interventional case series included five eyes of four patients who had poorly controlled chronic non-infectious uveitis. Retisert was implanted successfully using a novel approach.

View Article and Find Full Text PDF

Deferasirox nanosuspension loaded dissolving microneedles for ocular drug delivery.

Int J Pharm

October 2024

School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, United Kingdom. Electronic address:

Article Synopsis
  • Deferasirox (DFS) is an oral iron chelator used as a neuroprotectant for retinal diseases, but traditional oral administration has drawbacks like frequent dosing and first-pass metabolism.
  • Researchers developed a nanosuspension of DFS that significantly improved solubility and stability, and loaded it into polymeric microneedles (MNs) for painless drug delivery to the eye.
  • The microneedles showed effective scleral penetration and high drug deposition, indicating that this method is a promising alternative for delivering DFS to treat retinal conditions while maintaining cell viability and safety.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!